AKT1 and colorectal carcinoma: Further, our results indicated that PI3K/AKT signaling was closely involved in the anti-CRC activity of cincumol, and cincumol reduced the expression of p-AKT and p-PI3K, while exhibited no change on AKT and PI3K.